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Volume 49, Number 6 Pomposelli 1445first 3 months after the intervention. Patients with diabetes
and gangrene who undergo infrapopliteal interventions are
at significantly higher risk. Adjuncts to reduce tissue loss,
preserve limb function, and prevent recurrent infection are
needed to prevent limb loss despite PETAS, especially in
diabetic patients.
AUTHOR CONTRIBUTIONS
Conception and design: HD
Analysis and interpretation: MK, PL, LH, MD, HD
Data collection: HD
Writing the article: MK, HD
Critical revision of the article: MK, PL, LH, MD, HD
Final approval of the article: MK, PL, LH, MD, HD
Statistical analysis: HD
Obtained funding: Not applicable
Overall responsibility: HD
REFERENCES
1. Reifsnyder T, Grossman JP, Leers SA. Limb loss after lower extremity
bypass. Am J Surg 1997;174:149-51.
2. Dietzek AM, Gupta SK, Kram HB, Wengerter KR, Veith FJ. Limb loss
with patent infra-inguinal bypasses. Eur J Vasc Surg 1990;4:413-7.
3. Seeger JM, Pretus HA, Carlton LC, Flynn TC, Ozaki CK, Huber TS.
Potential predictors of outcome in patients with tissue loss who undergo
infrainguinal vein bypass grafting. J Vasc Surg 1999;30:427-35.
4. Carsten CG, Taylor SM, Langen EM, Crane MM. Factors associated
with limb loss despite a patent infrainguinal bypass graft. Am Surg
1998;64:33-8.
5. Leers SA, Reifsnyder T, Delmonte R, Caron M. Realistic expectations
for pedal bypass grafts in patients with end-stage renal disease. J Vasc
Surg 1998;28:976-83.
6. Johnson BL, Glickman MH, Bandyk DF, Esses GE. Failure of foot
salvage in patients with end-stage renal disease after surgical revascular-
ization. J Vasc Surg 1995;22:280-6.
7. Albers M, Romiti M, De Luccia N, Brochado-Neto FC, Nishimoto I,
Pereira CA. An updated meta-analysis of infrainguinal arterial recon-
struction in patients with end-stage renal disease. J Vasc Surg 2007;45:
536-42.
8. Edwards JM, Taylor LM, Porter JM. Limb salvage in end-stage renal
disease (ESRD): comparison of modern results in patients with and
without ESRD. Arch Surg 1988;123:116-48.
9. Semel L, Bredenberg CE, Aust JC. Limb loss despite functioning distal
bypass. J Cardiovasc Surg (Torino) 1989;30:473-8.
10. Elliott BM, Robison JG, Brothers TE, Cross MA. Limitations of
peroneal artery bypass grafting for limb salvage. J Vasc Surg 1993;18:
881-8.
11. BASIL Trial participants. Bypass versus angioplasty in severe ischemia of
the leg (BASIL): multicentre, randomized controlled trial. Lancet
2005;366:1925-34.
12. Nasr MK, McCarthy RJ, Hardman J, Chalmers A, Horrocks M. The
increasing role of percutaneous transluminal angioplasty in the primary
Israe
approach coupled with an increasingly aggressive philosophy to-management of critical limb ischemia. Eur J Vasc Endovasc Surg
2002;23:398-403.
13. Dosluoglu HH, O’Brien-Irr MS, Lukan J, Harris LM, Dryjski ML,
Cherr GS. Does preferential use of endovascular interventions by vas-
cular surgeons improve limb salvage, control of symptoms and survival
in patients presenting with critical limb ischemia? Am J Surg 2006;192:
572-6.
14. Hynes N, Mahendran B, Manning B, Andrews E, Courtrney D, Sultan
S. The influence of subintimal angioplasty on level of amputation and
limb salvage rates in lower limb critical limb ischemia. Eur J Vasc
Endovasc Surg 2005;30:291-9.
15. Cheng SWK, Ting ACW, Ho P. Angioplasty and primary stenting of
high-grade, long-segment disease: is it worthwhile? Ann Vasc Surg
2003;17:430-7.
16. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ,
Watkins MT, et al. Intermediate results of percutaneous endovascular
therapy of femoropopliteal occlusive disease: a contemporary series.J
Vasc Surg 2006;44:762-9.
17. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW,
McClean GK, et al. Reporting standards for lower extremity arterial
endovascular procedures. Society for Vascular Surgery/International
Society for Cardiovascular Surgery. J Vasc Surg 1993;17:1103-7.
18. Dormandy JA, Rutherford RB. Management of peripheral arterial
disease (PAD). TASC Working Group. TransAtlantic Inter-Society
Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
19. Mills JL, Taylor SM. Results of infrainguinal revascularization with
reversed vein conduits: a modern control series. Ann Vasc Surg 1991;
5:156-62.
20. Lantis JC, ConteMS, BelkinM,Whittemore AD,Mannick JA, Donald-
son MC. Infrainguinal bypass grafting in patients with end-stage renal
disease: improving outcomes? J Vasc Surg 2001;33:1171-8.
21. Abou-Zamzam AM, Gomez NR, Molkara A, Banta JE, Teruya TH, et
al. A prospective analysis of sritical limb ischemia: Factors leading to
major primary amputation versus revascularization. Ann Vasc Surg
2007;21:458-63.
22. Dosluoglu HH, Attuwaybi B, Cherr GS, Harris LM, Dryjski ML. The
management of ischemic heel ulcers and gangrene in the endovascular
era. Am J Surg 2007;194:600-5.
23. Abou-Zamzam AM, Moneta GL, Lee RW, Nehler MR, Taylor JM,
Porter JM. Peroneal bypass is equivalent to inframalleolar bypass for
ischemic pedal gangrene. Arch Surg 1996;131:894-8.
24. Darling RC, Chang BB, Paty PS, Lloyd WE, Leather RP, Shah DM.
Arterial reconstruction for limb salvage: is the terminal peroneal artery a
disadvantaged outflow tract? Surgery 1995;118:763-7.
25. Raftery KB, Belkin M, Mackey WC, O’Donnell TF. Are peroneal artery
bypass grafts hemodynamically inferior to other tibial artery bypass
grafts? J Vasc Surg 1994;19:964-8.
26. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML. Peroneal
artery-only runoff following endovascular interventions is effective for
limb salvage in patients with tissue loss. J Vasc Surg 2008;48:137-43.
27. Kalbaugh CA, Taylor SM, Cull DL, Blackhurst DW, Gray BH, et al.
Invasive treatment of chronic limb ischemia according to the Lower
Extremity Grading System (LEGS) score: a 6-month report. J Vasc Surg
2004;39:1268-76.Submitted Dec 14, 2008; accepted Feb 3, 2009.INVITED COMMENTARYFrank B. Pomposelli, MD, Harvard University, Beth
Kahn and associates have made the observation that amputa-
tion with a patent intervention or bypass performed for critical
limb ischemia occurred in nearly 40% of the patients losing limbs
after arterial bypass surgery and in an astounding 80% of those
having amputation after a catheter-based intervention. They at-
tribute these findings to having adopted an “endovascular first”l Deaconess Medical Center, Boston, Mass
wards limb salvage attempt even in marginal situations. They base
this approach on two assumptions:
The physiological insult to the patient treated with endovas-
cular therapy is far less than bypass surgery, so why not try it in
marginal situations?
There are no objective clinical criteria that can reliably predict the
likelihoodof limb salvage or limb loss in all patients prior to treatment.
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81% and 78%, respectively, in the endovascular and bypass cohorts,
a difference that was not statistically different.
On first pass, this approach would seem to be both very
reasonable and appropriate. Indeed, the authors state that this
policy reduced their primary amputation rate (amputation with no
attempt at revascularization) in their patients from 15% to 4%. The
question is, however, does reducing the rate of primary amputation
makes sense as a goal if some of the limbs intervened upon are best
served by primary amputation? In comparing the endovascular and
open surgery cohorts, significant differences did exist, with those in
the endovascular group being older, more frequently diabetic, and
presenting more commonly with gangrene and heel ulcers. This
may explain why this phenomenon was seen more commonly in
the endovascular cohort. The cause for amputation with a patent
intervention was failure to reverse ischemia in 21% of cases and this
same cause was attributed to 50% of the amputations with a patent
bypass surgery. These numbers seem high and raise questions
about the adequacy of the endovascular intervention performed or
the choice of outflow target in the bypass surgical group but more
likely reflect a decision to perform revascularization in some pa-
tients with no hopes of salvage. Is it really that difficult to deter-
mine who those patients are? Moreover, only one patient had a
bypass after a failed endovascular intervention. Were most patients
too ill to then have an attempt at a limb saving bypass, or was the
time delay such that the opportunity to salvage the limb was lost
before bypass could be performed? This exact scenario is why I
personally eschew the endovascular first philosophy for all patients.
The approach they describe for wound and foot care is com-
prehensive and mimics the approach that we use in our own
practice. It is therefore somewhat surprising that the cause of
amputation nearly 80% of the endovascular cohort and 30% of the
bypass cohort was attributed to continued tissue loss, “limb dys-
function after debridement,” or from recurrent infection, and anadditional 21% lost their limbs due to prosthetic graft infection.
Their approach to perform debridement and drainage procedures
at the same time as revascularization may explain this finding. Our
approach has always been to drain and débride infection first and
delay revascularization for few days until active spreading infection
has subsided. This is especially critical when placing prosthetic
grafts but may also be important when placing other foreign
materials like stents or stent grafts. An added advantage in delaying
revascularization is the ability to assess the viability of the foot as a
consequence of the infection. Often, the extent of infection and
necrosis is underestimated by physical examination especially in
diabetics, and its true extent only becomes clear during surgical
debridement under anesthesia with good lighting in the operating
room. The futility of limb salvage becomes evident when the
amount of destruction uncovered along with the amount of soft
tissue and bone removed to control infection renders the foot
nonfunctional even with revascularization. There is obviously no
advantage to attempting revascularization in this circumstance and
doing so inadvertently by performing bypass or angioplasty simul-
taneously will result in some amputations with patent interven-
tions.
The advent of endovascular therapy has dramatically altered
the treatment paradigm in patients with lower extremity ischemia.
The ability to salvage the limb at a lower physiological cost is
especially beneficial to our very ill or elderly patients. Yet while the
way we play the game may be different, the rules remain the same.
Arterial reconstruction is only one part of the complex treatment
strategy employed to treat critical limb ischemia. Applying it
wisely, be it bypass surgery or catheter based intervention, recog-
nizes the fact that, for some patients, it has no role at all. The
ultimate goal should be not to reduce the rate of primary amputa-
tion, but to eliminate the rate of needless amputations. The same
can be said for needless arterial interventions.
